Circulating MicroRNAs as Biomarkers for Sepsis
Sepsis represents a major cause of lethality during intensive care unit (ICU) treatment. Pharmacological treatment strategies for sepsis are still limited and mainly based on the early initiation of antibiotic and supportive treatment. In this context, numerous clinical and serum based markers have...
Main Authors: | Benz, Fabian, Roy, Sanchari, Trautwein, Christian, Roderburg, Christoph, Luedde, Tom |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730322/ |
Similar Items
-
Circulating MicroRNA-223 Serum Levels Do Not Predict Sepsis or Survival in Patients with Critical Illness
by: Benz, Fabian, et al.
Published: (2015) -
A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases
by: Sanchari Roy, et al.
Published: (2018-08-01) -
Circulating MicroRNA-150 Serum Levels Predict Survival in Patients with Critical Illness and Sepsis
by: Roderburg, Christoph, et al.
Published: (2013) -
Serum Levels of TNF Receptor Ligands Are Dysregulated in Sepsis and Predict Mortality in Critically Ill Patients
by: Roderburg, Christoph, et al.
Published: (2016) -
Circulating microRNAs as biomarkers - True Blood?
by: Schöler, Nathalie, et al.
Published: (2011)